Correction to: Adv Ther https://doi.org/10.1007/s12325-020-01602-9
The original article is published with an error in Table 1. The correct Table 1 is given below.
Table 1
Characteristics and Jadad score of the included studies
Study (first author + year of publication) | Nation | Duration | Blinding | Randomistation | Diagnoses | Intervention for Acarbose/control | Mean daily acarbose dose | The Jadad score |
|---|---|---|---|---|---|---|---|---|
Rachmani, R. 2004 | Israel | 24 weeks | Yes | Yes | Obesity, hypertension | Acarbose/placebo | 50 mg tid | 3 |
Bayraktar, F. 1998 | Turkey | 12 weeks | Yes | Yes | Obesity | Acarbose/placebo | 150 mg qd 2 weeks/300 mg qd 10 weeks | 3 |
Hauner, H. 2001 | Germany | 14 weeks | Yes | Yes | Obesity | Acarbose/placebo | 50 mg–300 mg | 3 |
Malaguarnera, M. 1999 | Italy | 20 weeks | Yes | Yes | Familial hypertriglyceridaemia | Acarbose/placebo | 50 mg bid | 4 |
Laube, H. 1998 | Germany | 12 weeks | Yes | Yes | Overweight with IGT | Acarbose/placebo | 100 mg qd | 3 |
Penna, I.A. 2007 | Brazil | 24 weeks | Yes | Yes | Obese, PCOS and insulin resistance | Acarbose/placebo | 50 mg tid | 6 |
Chiasson, J.L. 1996 | Canada | 16 weeks | Yes | Yes | Obese subjects with IGT | Acarbose/placebo | 50 mg tid 2 weeks/100 mg tid 14 weeks | 3 |
Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.